All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
QQQ / Invesco QQQ Trust, Series 1
|
|
|
|
|
|
|
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
VTGN / Vistagen Therapeutics, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
859319303 / Sterling Financial Corp
|
|
|
|
|
|
|
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ARKG / ARK ETF Trust - ARK Genomic Revolution ETF Put
|
|
|
|
|
|
|
|
KDMN / Kadmon Holdings Inc
|
|
|
|
|
|
|
|
DTIL / Precision BioSciences, Inc.
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
MRSN / Mersana Therapeutics, Inc.
|
|
|
|
|
|
|
|
SURF / Surface Oncology Inc
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
CASI / CASI Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
IWM / iShares Trust - iShares Russell 2000 ETF
|
|
|
|
|
|
|
|
TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TPST / Tempest Therapeutics, Inc.
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
FREQ / Frequency Therapeutics Inc Put
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
QQQ / Invesco QQQ Trust, Series 1 Put
|
|
|
|
|
|
|
|
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
APVO / Aptevo Therapeutics Inc.
|
|
|
|
|
|
|
|
MRNA / Moderna, Inc. Put
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
NUVB / Nuvation Bio Inc.
|
|
|
|
|
|
|
|
CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|